Related Experiment Video
Updated: Jul 15, 2025

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Effects of Rehabilitative Intervention for Augmenting Cough Function in Patients with Multiple System Atrophy
Takashi Asakawa1,2, Mieko Ogino3, Naomi Tominaga3
1Department of Clinical Medical Sciences, Rehabilitation Medicine, International University of Health and Welfare Graduate School of Medicine, Narita, Japan.
Maximum insufflation capacity (MIC) improves coughing in multiple system atrophy (MSA) patients. This finding may inform gastrostomy timing based on cough and respiratory function severity.
Area of Science:
- Neurology
- Pulmonology
- Rehabilitation Medicine
Background:
- Aspiration pneumonia, a leading cause of death in multiple system atrophy (MSA), stems from impaired cough function.
- Effective cough augmentation strategies are crucial for managing MSA patients and preventing fatal respiratory complications.
Purpose of the Study:
- To identify an effective method for improving cough in MSA patients.
- To establish criteria for gastrostomy use based on cough and respiratory dysfunction severity.
Main Methods:
- Eighteen probable MSA patients were divided into air stacking and non-air stacking groups.
- Peak cough flow (PCF) was measured under spontaneous coughing (SpC), SpC with maximum insufflation capacity (MIC), SpC with manually assisted cough (MAC), and SpC with both MIC and MAC.
- Receiver operating characteristic analysis was used to determine %FVC thresholds for identifying high-risk individuals (PCF < 160 L/min).
Main Results:
- Inspiration volume significantly increased with MIC in both groups.
- PCF significantly increased with MIC, particularly in the air stacking group.
- A %FVC below 59% was associated with PCF below 160 L/min, even with MIC application.
Conclusions:
- Maximum insufflation capacity (MIC) effectively enhances peak cough flow (PCF) in MSA patients.
- Gastrostomy timing should be considered based on the severity of cough and respiratory dysfunction, particularly when %FVC falls below 59%.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

